FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

908011000001108: Surmontil 10mg tablets (NRIM Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16701701000001114 Surmontil 10mg tablets (NRIM Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66034501000001115 Surmontil 10mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Surmontil 10mg tablets (NRIM Ltd) Is a Product containing precisely trimipramine (as trimipramine maleate) 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has active ingredient Trimipramine maleate false Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has active ingredient Trimipramine false Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Is a Surmontil true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Trimipramine true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has specific active ingredient Trimipramine maleate true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) Has basis of strength substance Trimipramine true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Surmontil 10mg tablets (NRIM Ltd) 84 tablet 6 x 14 tablets Is pack of False Surmontil 10mg tablets (NRIM Ltd) Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) 28 tablet 2 x 14 tablets Is pack of False Surmontil 10mg tablets (NRIM Ltd) Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) 28 tablet 2 x 14 tablets Has AMP True Surmontil 10mg tablets (NRIM Ltd) Inferred relationship Existential restriction modifier
Surmontil 10mg tablets (NRIM Ltd) 84 tablet 6 x 14 tablets Has AMP True Surmontil 10mg tablets (NRIM Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start